An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia
Condition(s):SchizophreniaLast Updated:July 31, 2014Completed
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:July 31, 2014Completed
Condition(s):SchizophreniaLast Updated:May 7, 2015Completed
Condition(s):Therapy-resistant DepressionLast Updated:August 10, 2022Withdrawn
Condition(s):Tourette’s DisorderLast Updated:October 7, 2021Completed
Condition(s):Psychotic DepressionLast Updated:August 20, 2012Completed
Condition(s):Depressive Disorder, MajorLast Updated:May 26, 2016Completed
Condition(s):DiabetesLast Updated:December 20, 2012Completed
Condition(s):Pharmacokinetics; Cytochrome P-450 CYP2D6; CYP3A4 Protein, HumanLast Updated:November 6, 2011Completed
Condition(s):Methamphetamine DependenceLast Updated:February 4, 2015Terminated
Condition(s):SchizophreniaLast Updated:July 19, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.